Cilmostim
Alternative Names: CSF-1; M-CSF; Macrophage colony-stimulating factor - Genetics Institute; Macstim; Recombinant human macrophage colony stimulating factor; rhM-CSFLatest Information Update: 24 Oct 2021
At a glance
- Originator Wyeth
- Developer Schering-Plough; Wyeth
- Class Macrophage colony stimulating factors
- Mechanism of Action Macrophage colony stimulating factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Hypercholesterolaemia
Most Recent Events
- 14 Aug 1996 Discontinued-II for Hypercholesterolaemia in USA (Unknown route)
- 07 Aug 1996 Discontinued-II for Cancer in USA (IV)
- 07 Aug 1996 Phase-II clinical trials for Hypercholesterolaemia in USA (Unknown route)